Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer

Estrogen receptor 1 (ESR1) mutations have been identified in hormone therapy–resistant breast cancer and primary endometrial cancer. Analyses in breast cancer suggest that mutant ESR1 exhibits estrogen-independent activity. In endometrial cancer, ESR1 mutations are associated with worse outcomes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanchard, Zannel, Vahrenkamp, Jeffery M., Berrett, Kristofer C., Arnesen, Spencer, Gertz, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724674/
https://www.ncbi.nlm.nih.gov/pubmed/31362937
http://dx.doi.org/10.1101/gr.244780.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724674/
https://www.ncbi.nlm.nih.gov/pubmed/31362937
http://dx.doi.org/10.1101/gr.244780.118

Ejemplares similares